GlassScriptPhysician profile
Jennifer L Earsing
NPI 1699054742
$6,779.99
in general payments reported to CMS, 2019-2025
46 companies · $1,170 in 2025
The $1,170 reported for 2025 was more than what 87% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,549 · 2022: $1,277 · 2023: $1,584 · 2024: $1,201 · 2025: $1,170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,775 · Education: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,774.78 |
| Education | $179.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $745.65 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $684.56 | 2021-2025 | |
| Lilly USA, LLC | $650.07 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $550.28 | 2021-2025 | |
| Astellas Pharma US INC | $521.97 | 2021-2025 | Veozah, Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $468.92 | 2021-2025 | Jardiance, Spiriva Respimat, Stiolto Respimat |
| Novo Nordisk INC | $277.96 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Exact Sciences Corporation | $265.48 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $248.38 | 2021-2025 | |
| Glaxosmithkline, LLC. | $245.97 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| E.R. Squibb & Sons, L.L.C. | $229.31 | 2021-2025 | Eliquis, Camzyos |
| Kowa Pharmaceuticals America, INC. | $153.00 | 2021-2023 | Seglentis, Livalo |
| Amarin Pharma, INC. | $144.30 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $137.81 | 2021-2025 | |
| Amgen INC. | $114.97 | 2021-2025 | Repatha, Otezla, Otezla |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Earsing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.